Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer

BACKGROUND & OBJECTIVES: An association between over-expression of proto-oncogene Her-2/neu and resistance to tamoxifen in estrogen receptor (ER) positive, primary and metastatic breast cancer has been suggested. HR+/Her-2/neu+ patients have a poor response to endocrine therapy, making this grou...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: James, Rani, Thriveni, K., Krishnamoorthy, Lakshmi, Deshmane, Vijayalaxmi, Bapsy, P.P., Ramaswamy, Girija
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100149/
https://ncbi.nlm.nih.gov/pubmed/21321422
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky